Literature DB >> 8940984

Deep breathing in children with severe malaria: indicator of metabolic acidosis and poor outcome.

M English1, C Waruiru, E Amukoye, S Murphy, J Crawley, I Mwangi, N Peshu, K Marsh.   

Abstract

Despite the frequent association of respiratory symptoms and signs with malarial morbidity and mortality in sub-Saharan Africa, the value of individual symptoms and signs has rarely been assessed. We have prospectively examined the association of individual clinical findings with the summary diagnosis of respiratory distress, outcome, and the presence of metabolic acidosis in children admitted with severe malaria to a Kenyan district hospital. Respiratory distress was present in 119 of the 350 children included in the study and in 23 of the 30 deaths (relative risk = 6.5, 95% confidence interval = 2.8-14.4). The features of a history of dyspnea, nasal flaring, and indrawing or deep breathing (Kussmaul's respiration) were individually most closely associated with the summary diagnosis of respiratory distress. Of these, deep breathing, which was sensitive (91%) and specific (83%) for the presence of severe metabolic acidosis (base excess < or = -12), is the best candidate sign to represent the prognostically important syndrome of malarial respiratory distress. Therefore, it warrants further prospective evaluation in different clinical settings and areas of different malaria endemicity.

Entities:  

Mesh:

Year:  1996        PMID: 8940984     DOI: 10.4269/ajtmh.1996.55.521

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  35 in total

Review 1.  Management of severe malaria in children: proposed guidelines for the United Kingdom.

Authors:  Kathryn Maitland; Simon Nadel; Andrew J Pollard; Thomas N Williams; Charles R J C Newton; Michael Levin
Journal:  BMJ       Date:  2005-08-06

2.  Impairment of functional capillary density but not oxygen delivery in the hamster window chamber during severe experimental malaria.

Authors:  Judith Martini; Irene Gramaglia; Marcos Intaglietta; Henri C van der Heyde
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 3.  Host-parasite interaction and morbidity in malaria endemic areas.

Authors:  K Marsh; R W Snow
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

4.  The epidemiology of clinical malaria among African children.

Authors:  R W Snow; K Marsh
Journal:  Bull Inst Pasteur       Date:  1998-03

5.  Characterisation of metabolic acidosis in Kenyan children admitted to hospital for acute non-surgical conditions.

Authors:  P Sasi; M English; J Berkley; B Lowe; M Shebe; R Mwakesi; G Kokwaro
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-10-27       Impact factor: 2.184

6.  The prognostic value of measures of acid/base balance in pediatric falciparum malaria, compared with other clinical and laboratory parameters.

Authors:  Charles R J C Newton; Clarissa Valim; Sanjeev Krishna; David Wypij; Christopher Olola; Tsiri Agbenyega; Terrie E Taylor
Journal:  Clin Infect Dis       Date:  2005-08-23       Impact factor: 9.079

Review 7.  ICU management of severe malaria.

Authors:  D Gupta; K Chugh; A Sachdev; A Soni
Journal:  Indian J Pediatr       Date:  2001-11       Impact factor: 1.967

8.  Diagnosing and treating attentional difficulties: a nationwide survey.

Authors:  I McKenzie; C Wurr
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

9.  Capillary refill: prognostic value in Kenyan children.

Authors:  A Pamba; K Maitland
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

10.  Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria.

Authors:  Sadik Mithwani; Leon Aarons; Gilbert O Kokwaro; Oneeb Majid; Simon Muchohi; Geoffrey Edwards; Sumia Mohamed; Kevin Marsh; William Watkins
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.